|
Status |
Public on Jul 01, 2009 |
Title |
DM009 |
Sample type |
RNA |
|
|
Source name |
Whole blood from non-infected patient with type 2 diabetes
|
Organism |
Homo sapiens |
Characteristics |
Age: 50 Gender: F Ethnicity: Not Hispanic or Latino Race: Asian Illness: Control/type 2 diabetes Treatment: Pathogen:
|
Extracted molecule |
total RNA |
Extraction protocol |
Tempus Spin Isolation Kit
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were generated following manufacturer protocols using the Illumina TotalPrep Amplification Kit from Ambion
|
|
|
Hybridization protocol |
HumanHT-12 Expression BeadChip
|
Scan protocol |
Illumina BeadScan Version 3.5.49.29917 (This information is in the .XML file)
|
Description |
The subject diagnosted type 2 diabetes
|
Data processing |
The data were analysed using BeadStudio version 3.1.3.0 using the average chip normalization method.
|
|
|
Submission date |
Jan 28, 2009 |
Last update date |
May 29, 2009 |
Contact name |
Damien Chaussabel |
E-mail(s) |
DChaussabel@benaroyaresearch.org
|
Organization name |
Baylor Institute for Immunology Research
|
Street address |
3434 Live Oak
|
City |
Dallas |
State/province |
TX |
ZIP/Postal code |
75204 |
Country |
USA |
|
|
Platform ID |
GPL6947 |
Series (1) |
GSE13015 |
Genomic Transcriptional Profiling Identifies a Blood Biomarker Signature for the Diagnosis of Septicemic Melioidosis |
|